Advanced search
Publication Cover
Journal of Nutritional & Environmental Medicine Volume 12, 2002 - Issue 1
Journal homepage
16
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The Detection of DNA Adducts (Risk Factors for DNA Damage). A Method for Genomic DNA, the Results and Some Effects of Nutritional Intervention

John McLaren Howard Biolab Medical Unit, 9 Weymouth Street, London W1W 6DB, UK
Pages 19-31 | Published online: 13 Jul 2009

  • Hemminki K, Dipple A, Shuker DEG, Kadlubar FF, Segerback D, Bartsch H. DNA Addicts: Identification and Biological Significance. IARC Scientific Publications no. 125. Lyon: International Agency for Research on Cancer, 1994.
  • Singer B, Bartsch H. Exocyclic DNA Addicts in Mutagenesis and Carcinogenesis. IARC Scientific Publications no. 150. Lyon: International Agency for Research on Cancer, 1999.
  • Umbenhauer D, Wild CP, Montesano R et al. O6-Methyldeoxyguanosin e in oesophageal DNA among persons at high risk from oesophageal cancer. Int J Cancer 1985; 36: 661-5.
  • Malins DC, Hainmanot R. Major alterations in the nucleotide structure of cancer of the female breast. Cancer Res 1991 ; 51: 5340-2.
  • Lawley PD, Harris G, Phillips E et al. Repair of chemical carcinogen-induce d damage in DNA of human lymphocytes and lymphoid cell lines. Studies on the kinetics of removal of O6-methylguanine and 3-methyladenine. Chem Biol Interactions 1986; 57: 107-21.
  • Tornqvist M, Osterman-Golkar S, Kautiainen A, Jensen S, Farmer PB, Ehrenberg L. Tissue doses of ethylene oxide in cigarette smokers determined from addict levels in hemoglobin. Carcinogenesis 1986; 7: 1519-21.
  • Post U, Marczynski B, Kasemann R, Peter H. Determination of 7-(2-hydroxyethyl)guanin e with gas chromatography/mass spectrometry as a parameter for genotoxicity of ethylene oxide. Arch Toxicol 1989; 13(Suppl.): 250-3.
  • Bodell WJ, Pongracz K, Kaur S, Burlingame AL, Lui SF, Rappaport SM. Investigation of styrene oxide-DNA adducts and their detection in workers exposed to styrene. Prog Clin Biol Res 1990; 34OC: 271-81
  • Autrup H, Bradley KA, Shamsuddin AKM, Wakhisi J, Wasunna A. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7'-guanyl)-3-hydroxyaflatoxin BI in human urine collected in Murang's district, Kenya. Carcinogenesis 1983; 4: 1193-5.
  • Herren DC, Shank RC. Methylated purines in human liver DNA after probable dimethylnitrosamine poisoning. Cancer Res 1980; 40: 3116-17.
  • Wild CP, Degan P, Bresil H et al. Quantification of 7-methyldeoxyguanosin e in peripheral blood cell DNA after exposure to methylating agents. Proc Am Assoc Cancer Res 1988; 29: 260.
  • Foiles PG, Miglietta LM, Akerkar SA, Everson RB, Hecht SS. Detection of O6-methyldeoxyguanosine in human placenta! DNA. Cancer Res 1988; 48: 4184-8.
  • Hall CN, Badawi AF, O'Connor PJ, Saffhill R. The detection of alkylation damage in the DNA of human gastrointestinal tissues. Br J Cancer 1991 ; 64: 59-63.
  • Carmella SG, Kagan SS, Kagan M et al. Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff-dippers, smokers and non-smokers. Cancer Res 1990; 50: 5438-45.
  • Talaska G, Schamer M, Skipper P et al. Detection of carcinogen-DN A adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicfty. Cancer Epidemiol Biomarkers Prev 1991; 1: 61-6.
  • Talaska G, Al-Juburi AZSS, Kadludar FF. Smoking-related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanasin-8-yl)-4-aminobipheny 1 as a major adduct. Proc Natl Acad Sei USA 1991; 88: 5350-4.
  • Kalubar FF, Talaska G, Lanf NP, Benson RW, Roberts DW. Assessment of exposure and susceptibil ity to aromatic amine carcinogens. In: Bartsch H, Hemminki K, O'Neill IK (eds) Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. IARC Scientific Publications no. 89. Lyon: International Agency for Research on Cancer, 1988, 166-74.
  • Wilson VL, Weston A, Manchester DK et al. Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis 1989; 10: 2149-53.
  • Kadrelik RK, Talaska G, DeBord DG, Osorio AM, Kadlubar FF. 4,4'-Methylene-bis(2-chloroanaline)-DNA adduct analysis in human exfoliated urothelial cells by 32P-postlabeling. Cancer Epidemiol Biomarkers Prev 1992; 2: 63-9.
  • Chaudhary AK, Nokubo M, Reddy GR et al. Detection of endogenous malandialdehyde deoxyguanosine adducts in human liver. Science 1994; 265: 1580-2.
  • Vaca CE, Fang J-L, Mutanen M, Valsta L. 32P-postlabeling determination of DNA adducts of malandialdehyde in humans: total white blood cells and breast tissue. Carcinogenesi s 1995; 16: 1847-51.
  • Nath RG, Chung F-L. Detection of exocyclic 1 ,N2-propanodeoxyguanosin e adducts as common DNA lesions in rodents and humans. Proc Natl Acad Sei 1994; 91: 7491-5.
  • Swenberg JA, La DK, Scheller NA, Wu K-Y. Dose-response relationships for carcinogens. Toxicol Lett 1995; 82/83: 751-6.
  • Fang JL, Vaca CE, Valsta LM, Mutanen M. Determination of DNA adducts of malandialdehyde in humans: effects of dietary fatty acid composition. Carcinogenesi s 1996; 17: 1035-40.
  • Rouzer CA, Chaudhary AK, Nokubo M et al. Analysis of the malandialdehyde- 2'-deoxyguanosine adduct, pyrimidopurinone, in human leukocyte DNA by gas chromatography /electron capture negative ionization-mass spectrometry. Chem Res Toxicol 1997; 10: 181-8.
  • Wang M, Dhingra K, Hittleman WN, Liehr JG, de Andrade M, Li D. Lipid peroxidation-induce d putative malandialdehyde-DN A adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev 1996; 5: 705-10.
  • La DK, Swenberg JA. DNA adducts: biological markers of exposure and potential applications to risk assessment. Mutt Res 1996; 365: 129-46.
  • Lefebvre P, Zak P, Laval F. Induction of O6-methylguanine-DNA-methyltransferas e and N3-methyladenine-DNA-glycosylase in human cells exposed to DNA-damaging agents. DNA Cell Biol 1993; 12: 233-41.
  • Swenberg JA, Fedtke N, Ciroussel F, Barbin A, Bartsch H. Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesi s 1992; 13: 727-9.
  • Nath RG, Ocando JE, Guttenplan JB, Chung E-L. 1 ,N2-Propanodeoxyguanosin e adducts: potential new biomarkers of smoking induced DNA damage in human oral tissue. Cancer Res 1998; 58: 581-4.
  • Wilson VL, Foiles PG, Chung F-L, Povey AC, Frank AA, Harris CC. Detection of acrolein and crotonaldehyde DNA adducts in cultured human cells and canine peripheral blood lymphocytes by 31P-postlabeling and nucleotide chromatography. Carcinogenesi s 1991; 12: 1483-90.
  • Nair J, Barbin A, Guichard Y, Bartsch H. 1 ,N6-Ethenodeoxyadenosin e and 3,N4-ethenodeoxycytin e in liver DNA from humans and untreated rodents detected by immunoaffinity/P32-postlabeling. Carcinogenesis 1995; 16: 613-17.
  • Levay G, Ross D, Bodell WJ. Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesi s 1993; 14: 2329-34.
  • Lindstrom AB, Yeowell-O'Connell K, Waidyanatha S, McDonald TA, Golding BT, Rappaport SM. Formation of hemoglobin and albumin adducts of bexene oxide in mouse, rat and human blood. Chem Res Toxicol 1998; 11:301-10.
  • Fang FL, Vaca CE. Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesi s 1997; 18: 627-32.
  • Leuratti C, Bingham S, Hughes R et al. Detection by HPLC/32P-postlabelling of malandialdehyde- deoxyguanosine monophosphate in human blood and tissue DNA in relation to diet and H. pylori infection. Proc AACR 1997; 39: 353.
  • Leuretti C, Shigh R, Lagneau C et al. Determination of malandialdehyde-induce d DNA damage in human tissues using immunoslot-blot assay. Carcinogenesi s 1998; 19: 1919-24.
  • Yang K, Fang J-L, Hemminsky K. Abundant lipophilic-DNA addicts in human tissues. Cancer Epidemiol Biomarkers Prev 1998; 5: 705-10.
  • Mamett LJ. Chemistry and biology of DNA damage by malandialdehyde. In: Singer B, Bartsch H (eds) Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. IARC Scientific Publications no. 150. Lyon: International Agency for Research on Cancer, 1999, 17-27.
  • Ambs S, Hussein SP, Marrogi AJ, Harris CC. Cancer-prone oxyradical overload disease. In: Singer B, Bartsch H (eds) Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. IARC Scientific Publications no. 150. Lyon: International Agency for Research on Cancer, 1999, 295-302.
  • Singer B, Bartsch H. Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. IARC Scientific Publications no. 150. Lyon: International Agency for Research on Cancer, 1999. See appendices to papers by Chenna and Singer; Sagi and Singer; and Singer and Hang, pp. 351-5.
  • Lawley PD. From fluorescence spectra to mutational spectra, a historical overview of DNA-reactive compounds. In: Hemminki K, Dipple A, Shuker DEG, Kadlubar FF, Segerback D, Bartsch H (eds) DNA Adducts: Identification and Biological Significance. IARC Scientific Publications no. 125. Lyon: International Agency for Research on Cancer, 1994, 3-16.
  • Animal carcinogenicity data. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 74, Surgical Implants and other Foreign Bodies. Lyon: International Agency for Research on Cancer, 1999, 306-10.
  • Case CP, Lankamer VG, Howell RT et al. Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop ReI Res 1996; 329(Suppl.): S269-79.
  • Cole BJ, Schultz E, Similari TF, Hajdu SI, Krauss ES. Malignant fibrous histiocytoma at the site of total hip replacement: review of the literature and case report. Skel Radiol 1997; 26: 559-63.
  • Coleman MP. Cancer risk from orthopedic prostheses. Ann Clin Lab Sei 1996; 26: 139-46.
  • Costa M. Nonmutagenic mechanisms of nickel Carcinogenesis: inactivation of critical genes by nickel-induced methylation and chromatin decondensation. In: Dungworth DL, Adler KB, Harris CC, Plopper CG (eds) Correlations Between In Vitro and In Vivo Investigations in Inhalation Toxicology. Washington DC: ILSI Press, 1997, 359-66.
  • Doran A, Law FC, Alien MJ, Rushton N. Neoplastic transformation of cells by soluble but not paniculate forms of metals used in orthopaedic implants. Biomaterials 1998; 19: 751-9.
  • Fryzek JP, Mellelkjaer L, McLaughlin JK, Blot WJ, Olsen JH. Cancer risk among patients with finger and hand joint and temporo-mandibular joint prostheses in Denmark. Int J Cancer 1999; 81: 723-5.
  • Furst A, Cassetta D. Carcinogenicity of nickel by different routes (abstract no. 121). Proc Am Assoc Cancer Res 1973; 14: 31.
  • Gaechter A, Alroy J, Andersso n GBJ, Galante J, Rostoker W, Schajowicz F. Metal Carcinogenesis : a study of the carcinogenic activity of solid metal alloys in rats. J Bone Joint Surg 1997; 59A: 622-4.
  • Gillespie WJ, Henry DA, O'Connell DL et al. Development of hematopoietic cancers after implantation of total joint replacement. Clin Orthopaed ReI Res 1996; 329(Suppl.): S290-6.
  • Heath JC, Freeman MA, Swanson SA. Carcinogenic properties of wear particles from prostheses made of cobalt-chromium alloy. Lancet 1971 ; i: 564-6.
  • Hueper HC. Experimental studies in metal Carcinogenesis. I. Nickel cancers in rats. Texas Rep Biol Med 1952; 16: 167-86.
  • Hueper HC. Experimental studies in metal Carcinogenesis. VII. Tissue reactions to parentally introduced powdered metallic chromium and chromite ore. J Natl Cancer Inst 1955; 16: 447-62.
  • Hueper HC. Experimental studies in metal Carcinogenesis. IV. Cancer produced by parentally introduced metallic nickel. J Natl Cancer Inst 1955; 16: 55-67.
  • Hueper HC, Payne WW. Experimental studies in metal Carcinogenesis. Chromium, nickel, iron, arsenic. Arch Environ Health 1962; 5: 445-62.
  • Ivankovic S, Seller WJ, Lehmann E, Komitowski D, Frolich N. Different carcinogenicft y of two nickel alloys following intratracheal administration in the hamster (abstract no. 103). Naunyn-Schmiedelberg Arch Pharmacol 1987; 335: R26.
  • Jasmin G, Riopelle JL. Renal carcinomas and erythrocytosi s in rats following intra-renal injection of nickel subsulfide. Lab Invest 1976; 35: 71-8.
  • Judde JG, Breillout F, Clemenceau C, Poupon MF, Jasmin C. Inhibition of rat natural killer cell function by carcinogenic nickel compounds: preventative action of manganese. J Natl Cancer Inst 1987; 78: 1185-90.
  • Kumar K. Osteosarcoma associated with metal implant. Int Orthop (SICOT) 1996; 20: 335-6.
  • Lee YS, Pho RWH, Nather A. Malignant fibrous histiocytoma at site of metal implant. Cancer 1984; 54: 2286-9.
  • Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Cancer incidence in Finnish hip replacement patients from 1980 to 1995. A nationwide cohort study involving 31,651 patients. J Arthroplasty 1999; 14: 272-80.
  • Penman HG, Ring PA. Osteosarcoma in association with total hip replacement. J Bone Joint Surg 1984; 66B: 632-4.
  • Sinibaldi K, Rosen H, Liu S, DeAngelis M. Tumors associated with metallic implants in animals. Clin Orthop 1976; 118:257-66.
  • Sunerman FW Jr. Carcinogenicity of nickel compounds in animals. In: Sunderman FW Jr (ed.) Nickel in the Human Environment. IARC Scientific Publications no. 53 Lyon: International Agency for Research on Cancer, 1984, 127-42.
  • Theegarten D, Sardisong F, Philippou E. Malignant fibrous histiocytoma associated with total hip replacement. Chirurg 1995; 66: 158-61 [in German].
  • Van der List JJJ, van Horn JR, Slooff TJJH, Naudin ten Gate L. Malignant epitheloid hemangioen-dothelioma at site of a hip prosthesis. Acta Orthop Scand 1988; 59: 328-30.
  • Randerath K, Li D, Moorthy B, Randerath E. I-compounds-Endogenous DNA markers of nutritional status, ageing, tumor promotion and carcinogenesis. In: Phillips DH, Castegnaro M, Bartsch H (eds) Postlabelling Methods for Detection of DNA Adducts. IARC Scientific Publications no. 124. Lyon: International Agency for Research on Cancer, 1993, 157-65.
  • Hemminki K, Dipple A, Shuker DEG, Kadlubar FF, Segerback D, Bartsch H. DNA Adducts: Identification and Biological Significance. IARC Scientific Publications no. 125. Lyon: International Agency for Research on Cancer, 1994, 73-106, 199-216, 453-6.
  • Singer B, Hang B. Mammalian enzymatic repair of etheno and para-benzoquinon e exocyclic adducts derived from the carcinogens vinyl chloride and benzene. In: Singer B, Bartsch H (eds) Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. IARC Scientific Publications no. 150. Lyon: International Agency for Research on Cancer, 1999, 233-47.
  • Roseberg JM. Structure and function of restriction endonucleases. Curr Opin Struct Biol 1991; 1: 104-13.
  • Newman M, Strzelecta T, Domer LF, Schildkraut I, Aggarwal AK. Structure of restriction endonuclease BamHI and its relationship to EcoRI. Nature 1994; 368: 660-4.
  • Wells RD, Klein RD, Singleton CK. Type II restriction enzymes. In: Boyer PD (ed.) The Enzymes, 3rd edn, Vol. 14. New York: Academic Press, 1981, 137-56.
  • Voet D, Voet JG. Restriction endonucleases. In: Biochemistry, 2nd edn. New York: John Wiley & Sons, 1995, 883-8.
  • Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001; 47: 1183-9.
  • Feinberg AP. DNA methylation, genomic imprinting and cancer. Curr Top Microbiol Immunol 2000; 249: 87-99.
  • Zeschnigk M, Schmilz B, Dittrich B, Suiting K, Horsthemke B, Doerfler W. Imprinting segments in the human genome: different DNA methylation patterns in the Prader-Willi/Angelman syndrome region as determined by the genomic sequencing method. Hum MoI Genet 1997; 6: 387-95.
  • Sheffield VC, Cox DR, Lerman LS, Myers RM. Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction in improved detection of single base changes. Proc Nail Acad Sei USA 1989; 86: 232-6.
  • Shuker DEG, Bartsch H. DNA adducts of nitrosamines. In: Hemminki K, Dipple A, Shuker DEG, Kadlubar FF, Segerback D, Bartsch H (eds) DNA Adducts: Identification and Biological Significance. IARC Scientific Publications no. 125. Lyon: International Agency for Research on Cancer, 1994, 73-89.
  • Hecht SS, Peterson LA, Spratt TE. Tobacco-specific nitrosamines. In: Hemminki K, Dipple A, Shuker DEG, Kadlubar FF, Segerback D, Bartsch H (eds) DNA Adducts: Identification and Biological Significance. IARC Scientific Publications no. 125. Lyon: International Agency for Research on Cancer, 1994, 91-106.
  • Chesters JK. Trace element-gene interactions with particular reference to zinc. Proc Nutr Soc 1991 ; 50: 123-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.